Pharmaceutical

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders’ Equity Up 8.8% to $35M

Stable revenue and gross profit despite cost-cutting initiatives, indicating the strength of underlying segments and brands.Solid liquidity position, with cash...

NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial – Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information

Conference Call Scheduled for Friday, November 15 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 14, 2024) - Elite...

Health Union Expands Industry-Leading Portfolio of Online Health Communities With New Focus in Mental Health and Cardiometabolic Conditions

PHILADELPHIA, Nov. 14, 2024 /PRNewswire/ -- Health Union, the leading digital health company building online communities that empower people to live...

Korea Innovation Foundation selects 2 innovative biotech companies, FUST Lab and Edenlux for Global Technology Commercialization Support Program (North America)

Pioneering Health: Innovations in Korea's Biotech Sector SEOUL, South Korea and NEW YORK, Nov. 14, 2024 /PRNewswire/ -- The Korea...

Bumrungrad International Hospital Partners with Golden Helix to Advance Genomics for Cancer and Hereditary Disease Initiatives

BOZEMAN, Mont., Nov. 14, 2024 /PRNewswire/ -- Bumrungrad International Hospital, a leading global healthcare provider based in Bangkok, Thailand, and...

Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,...

error: Content is protected !!